Basic Information
| RNALocate ID: | RLID:11000837 |
| RNA Symbol: | hsa-miR-25-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-25 |
| RNA ID: | miRBase:MIMAT0000081 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21670082 |
| Tissue/Cell Line: | Renal cancer cells |
| Method: | qRT-PCR|TaqMan miRNA assay |
| Condition: | Human CD105+ and CD105- renal carcinomas cells |
| Description: | Exosomal miRNAs as potential biomarkers and therapeutic targets. Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001340 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001341 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001342 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001343 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001344 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001345 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001346 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11000835 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000836 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000838 | Exosome | Ovarian follicular fluid | 22116803 |
| RLID:11000839 | Exosome | Breast milk | 22211110 |
| RLID:11000840 | Exosome | Brain tissue | 23382797 |
| RLID:11000841 | Exosome | Plasma | 23663360 |
| RLID:11000842 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11000843 | Extracellular Vesicle | Liposarcoma cell lines (Lipo224B|Lipo246|Lipo863|LPS141)|Preadipocytes | 28588009 |
| RLID:11000844 | Extracellular vesicle | Plasma | 32498409 |
| RLID:11000845 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000846 | Microvesicle | Plasma | 23077538 |
| RLID:11000847 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000848 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000017 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000280 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-25-3p | Splenic marginal zone lymphoma | MNDR-E-MI-32729 |
| MNDR | hsa-miR-25-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-32730 |
| MNDR | hsa-miR-25-3p | Oral squamous cell carcinoma | MNDR-E-MI-32731 |
| MNDR | hsa-miR-25-3p | Large cell neuroendocrine cancer | MNDR-E-MI-32732 |
| MNDR | hsa-miR-25-3p | Medulloblastoma | MNDR-E-MI-32733 |
| MNDR | hsa-miR-25-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-32734 |
| MNDR | hsa-miR-25-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-32735 |
| MNDR | hsa-miR-25-3p | Lymphoma | MNDR-E-MI-32736 |
| MNDR | hsa-miR-25-3p | Lymphoma non-hodgkin | MNDR-E-MI-32737 |
| MNDR | hsa-miR-25-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-32738 |
| MNDR | hsa-miR-25-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-32739 |
| MNDR | hsa-miR-25-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-32740 |
| MNDR | hsa-miR-25-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-32741 |
| MNDR | hsa-miR-25-3p | Her2-receptor positive breast cancer | MNDR-E-MI-32742 |
| MNDR | hsa-miR-25-3p | Anaplastic thyroid carcinoma | MNDR-E-MI-32743 |
| MNDR | hsa-miR-25-3p | Prostate cancer | MNDR-E-MI-32744 |
| MNDR | hsa-miR-25-3p | Gastric cancer | MNDR-E-MI-32745 |
| MNDR | hsa-miR-25-3p | Gastric lymphoma | MNDR-E-MI-32746 |
| MNDR | hsa-miR-25-3p | Alzheimer disease | MNDR-E-MI-32747 |
| MNDR | hsa-miR-25-3p | Intracranial aneurysm | MNDR-E-MI-32748 |
| MNDR | hsa-miR-25-3p | Bladder cancer | MNDR-E-MI-32749 |
| MNDR | hsa-miR-25-3p | Esophageal carcinoma | MNDR-E-MI-32750 |
| MNDR | hsa-miR-25-3p | Dysautonomia familial | MNDR-E-MI-32751 |
| MNDR | hsa-miR-25-3p | Malaria | MNDR-E-MI-32752 |
| MNDR | hsa-miR-25-3p | Leukemia | MNDR-E-MI-32753 |
| MNDR | hsa-miR-25-3p | Cardiovascular disease | MNDR-E-MI-32754 |
| MNDR | hsa-miR-25-3p | Moyamoya disease | MNDR-E-MI-32755 |
| MNDR | hsa-miR-25-3p | Lung cancer | MNDR-E-MI-32756 |
| MNDR | hsa-miR-25-3p | Down syndrome | MNDR-E-MI-32757 |
| MNDR | hsa-miR-25-3p | Parkinson disease | MNDR-E-MI-32758 |
| MNDR | hsa-miR-25-3p | Machado-joseph disease | MNDR-E-MI-32759 |
| MNDR | hsa-miR-25-3p | Basal-like breast cancer | MNDR-E-MI-32760 |
| MNDR | hsa-miR-25-3p | Pancreatic cancer | MNDR-E-MI-32761 |
| MNDR | hsa-miR-25-3p | Melanoma | MNDR-E-MI-32762 |
| MNDR | hsa-miR-25-3p | Lesch-nyhan syndrome | MNDR-E-MI-32763 |
| MNDR | hsa-miR-25-3p | Atherosclerosis | MNDR-E-MI-32764 |
| MNDR | hsa-miR-25-3p | Rectum adenocarcinoma | MNDR-E-MI-32765 |
| MNDR | hsa-miR-25-3p | Nephroblastoma | MNDR-E-MI-32766 |
| MNDR | hsa-miR-25-3p | Colon cancer | MNDR-E-MI-32767 |
| MNDR | hsa-miR-25-3p | Ischemic attack transient | MNDR-E-MI-32768 |
| MNDR | hsa-miR-25-3p | Colon adenocarcinoma | MNDR-E-MI-32769 |
| MNDR | hsa-miR-25-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-32770 |
| MNDR | hsa-miR-25-3p | Familial ovarian cancer | MNDR-E-MI-32771 |
| MNDR | hsa-miR-25-3p | Prostate adenocarcinoma | MNDR-E-MI-32772 |
| MNDR | hsa-miR-25-3p | Iga glomerulonephritis | MNDR-E-MI-32773 |
| MNDR | hsa-miR-25-3p | Invasive ductal carcinoma | MNDR-E-MI-32774 |
| MNDR | hsa-miR-25-3p | Glioblastoma | MNDR-E-MI-32775 |
| MNDR | hsa-miR-25-3p | Astrocytoma | MNDR-E-MI-32776 |
| MNDR | hsa-miR-25-3p | Glioma | MNDR-E-MI-32777 |
| MNDR | hsa-miR-25-3p | Chronic obstructive pulmonary disease | MNDR-E-MI-32778 |
| MNDR | hsa-miR-25-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-32779 |
| MNDR | hsa-miR-25-3p | Temporal lobe epilepsy | MNDR-E-MI-32780 |
| MNDR | hsa-miR-25-3p | Coronary artery disease | MNDR-E-MI-32781 |
| MNDR | hsa-miR-25-3p | Liver cancer | MNDR-E-MI-32782 |
| MNDR | hsa-miR-25-3p | Uterine cancer | MNDR-E-MI-32783 |
| MNDR | hsa-miR-25-3p | Cervical adenocarcinoma | MNDR-E-MI-32784 |
| MNDR | hsa-miR-25-3p | Gastric adenocarcinoma | MNDR-E-MI-32785 |
| MNDR | hsa-miR-25-3p | Cervical squamous cell carcinoma | MNDR-E-MI-32786 |
| MNDR | hsa-miR-25-3p | Lung squamous cell carcinoma | MNDR-E-MI-32787 |
| MNDR | hsa-miR-25-3p | Lung adenocarcinoma | MNDR-E-MI-32788 |
| MNDR | hsa-miR-25-3p | Thyroid carcinoma | MNDR-E-MI-32789 |
| MNDR | hsa-miR-25-3p | Ovarian carcinoma | MNDR-E-MI-32790 |
| MNDR | hsa-miR-25-3p | Bladder urothelial carcinoma | MNDR-E-MI-32791 |
| MNDR | hsa-miR-25-3p | Pancreatic adenocarcinoma | MNDR-E-MI-32792 |
| MNDR | hsa-miR-25-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-32793 |
| MNDR | hsa-miR-25-3p | Carcinoma renal cell | MNDR-E-MI-32794 |
| MNDR | hsa-miR-25-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-32795 |
| MNDR | hsa-miR-25-3p | Clear cell renal cell carcinoma | MNDR-E-MI-32796 |
| MNDR | hsa-miR-25-3p | Adenocarcinoma of esophagus | MNDR-E-MI-32797 |
| MNDR | hsa-miR-25-3p | Cholangiocarcinoma | MNDR-E-MI-32798 |
| MNDR | hsa-miR-25-3p | Esophageal cancer | MNDR-E-MI-32799 |
| MNDR | hsa-miR-25-3p | Liver cirrhosis | MNDR-E-MI-32800 |
| MNDR | hsa-miR-25-3p | Small cell lung cancer | MNDR-E-MI-32801 |
| MNDR | hsa-miR-25-3p | Stomach carcinoma | MNDR-E-MI-32802 |
| MNDR | hsa-miR-25-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-32803 |
| MNDR | hsa-miR-25-3p | Hepatocellular carcinoma | MNDR-E-MI-32804 |
| MNDR | hsa-miR-25-3p | Familiar ovarian carcinoma | MNDR-E-MI-32805 |
| MNDR | hsa-miR-25-3p | B-cell lymphoma | MNDR-E-MI-32806 |
| MNDR | hsa-miR-25-3p | Rheumatoid arthritis | MNDR-E-MI-32807 |
| MNDR | hsa-miR-25-3p | T-cell leukemia | MNDR-E-MI-32808 |
| MNDR | hsa-miR-25-3p | Retinoblastoma | MNDR-E-MI-32809 |
| MNDR | hsa-miR-25-3p | Barrett's adenocarcinoma | MNDR-E-MI-32810 |
| MNDR | hsa-miR-25-3p | Hodgkin lymphoma | MNDR-E-MI-32811 |
| MNDR | hsa-miR-25-3p | Burkitt lymphoma | MNDR-E-MI-32812 |
| MNDR | hsa-miR-25-3p | Tonsil cancer | MNDR-E-MI-32813 |
| MNDR | hsa-miR-25-3p | Colorectal cancer | MNDR-E-MI-32814 |
| MNDR | hsa-miR-25-3p | Nasopharynx carcinoma | MNDR-E-MI-32815 |
| MNDR | hsa-miR-25-3p | Multiple myeloma | MNDR-E-MI-32816 |
| MNDR | hsa-miR-25-3p | Ovarian epithelial cancer | MNDR-E-MI-32817 |
| MNDR | hsa-miR-25-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-32818 |
| MNDR | hsa-miR-25-3p | Ependymoma | MNDR-E-MI-32819 |
| MNDR | hsa-miR-25-3p | Nasopharyngeal cancer | MNDR-E-MI-32820 |
| MNDR | hsa-miR-25-3p | Prostatic neoplasms | MNDR-E-MI-32821 |
| MNDR | hsa-miR-25-3p | Sarcopenia | MNDR-E-MI-32822 |
| MNDR | hsa-miR-25-3p | Stroke lacunar | MNDR-E-MI-32823 |
| MNDR | hsa-miR-25-3p | Barrett's carcinogenesis | MNDR-E-MI-32824 |
| MNDR | hsa-miR-25-3p | Breast cancer her3+ negative | MNDR-E-MI-32825 |
| MNDR | hsa-miR-25-3p | Duke C | MNDR-E-MI-32826 |
| MNDR | hsa-miR-25-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-32827 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABHD13 | Homo sapiens | RR00025339 |
TOP